Adamis Pharmaceuticals Corporation - stock earnings
Stock symbol ADMP is outdated, potentially delisted? Maybe it is available on other exchange?
ADMP Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q1 | -8.9 million USD | 1.5 million USD |
| 2022Q4 | -3.3 million USD | 2.2 million USD |
| 2022Q3 | -4.4 million USD | 1.5 million USD |
| 2022Q2 | -8.4 million USD | 39847 USD |
| 2022Q1 | -10.4 million USD | 1.2 million USD |
| 2021Q4 | -8.8 million USD | -1.2 million USD |
| 2021Q3 | -12.4 million USD | 759962 USD |
| 2021Q2 | -9.3 million USD | 4.0 million USD |
| 2021Q1 | -15.4 million USD | 4.1 million USD |
| 2020Q4 | -20.4 million USD | 3.6 million USD |
| 2020Q3 | -7.5 million USD | 4.3 million USD |
| 2020Q2 | -11.3 million USD | 3.9 million USD |
| 2020Q1 | -10.3 million USD | 4.7 million USD |
ADMP Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -26.5 million USD | 4.8 million USD |
| 2021 | -45.8 million USD | 2.2 million USD |
| 2020 | -49.4 million USD | 2.8 million USD |
| 2019 | -27.5 million USD | 22.1 million USD |
| 2018 | -39.0 million USD | 15.1 million USD |
| 2017 | -25.5 million USD | 13.1 million USD |
ADMP
Price: $0.78
52 week price:
Earnings Per Share: -0.08 USD
P/E Ratio: -1.57
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 771900
Ebitda: -6.0 millionMarket Capitalization: 13.5 million